• Our team of analysts have screened the titles of the abstracts in preparation for abstract release and presentations. So far, 41 abstract titles have been identified as relevant to trial or drug pages on Beacon Oncolytic Viruses.
  • The pre-conference planner lists the abstract titles, categorised by viral family, and also includes abstracts numbers, and links to the associated Beacon trial or drug page where possible.
  • Data from AACR 2022 will be populated on Beacon over the coming weeks. Remember that you can keep an eye on the trials and drugs that you’re most interested in by adding them to your personal watch list on Beacon. This will send you a notification when the page gets updated.

Find out more

 

This insight and data is part of the subscription to Beacon Oncolytic Viruses.

 

Find out more

Speak with our Team

Our dedicated team can help you with questions by showing you how this insight and data is collated on Beacon.

Gregory Kavalerov  

 

Request a Demo

About Beacon Targeted Therapies

We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.

 

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find more

logo
Verified by MonsterInsights